Nevro (NVRO) Reports Prelim Q4 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Nevro Corp (NVRO) PT Raised to $92 at Piper Sandler on Physician Survey Results
January 7, 2022 9:05 AM ESTPiper Sandler analyst Adam Maeder raised the price target on Nevro Corp (NYSE: NVRO) to $92.00 (from $90.00) after data from a 25 U.S. endocrinologist physician survey reaffirmed the positive view of the PDN opportunity.
The analyst reiterated the Neutral rating, stating "the... More
Morgan Stanley Downgrades Nevro Corp (NVRO) to Equalweight
January 7, 2022 4:16 AM ESTMorgan Stanley analyst David Lewis downgraded Nevro Corp (NYSE: NVRO) from Overweight to Equalweight with a price target of $100.00 (from $140.00).
For an analyst ratings summary and ratings history on Nevro Corp click here. For more ratings news on Nevro Corp click here.
Shares of Nevro Corp closed at $83.73 yesterday.
... More